As the global economy mends, the 2021 growth of Valacyclovir will have significant change from previous year. According to our (LP Information) latest study, the global Valacyclovir market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Valacyclovir market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Valacyclovir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Valacyclovir market, reaching US$ million by the year 2028. As for the Europe Valacyclovir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Valacyclovir players cover GSK, Mylan Pharmaceuticals, Cobalt Laboratories (Allergan), and Sorres Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Valacyclovir market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Capsule
Granules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio